IDYA Ideaya Biosciences Inc
Company Analysis
Latest News
🟢 IDYA extends move to 5.0% up
IDYA is trading at $36.67, up 5.0% versus the comparison close of $34.91 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 IDYA is trading 4.4% up today as investors refocus on cash runway after $300M offering
IDYA is trading 4.4% up today at $36.44 as the stock rebounds from selling pressure tied to its recently priced $300 million stock and warrant offering. •...
Ideaya's $345M Cash Grab Fuels the Pipeline But Stings Shareholders — Can Drug Data Justify the Dilution?
Shares slid 7.7% to $32.22 as the aftershocks from Ideaya Biosciences' massive discounted stock sale continue rippling through the trading floor, leaving...
🔴 IDYA is trading 7.7% down today after pricing a $300M stock and warrant offering at a discount
IDYA is trading 7.7% down at $32.22 after recently pricing a $300 million underwritten stock and warrant offering at a discount to its prior close. • The $300...
IDEAYA Biosciences Appoints CEO Yujiro S. Hata as Chairman of the Board
IDEAYA Biosciences announced changes to its board leadership, appointing President and CEO Yujiro S. Hata as the new Chairman of the Board. The company also...
Ideaya Biosciences targets 2026 darovasertib filing, following successful clinical trial
Ideaya Biosciences emerged as a leading small-cap oncology firm following the ASCO 2026 conference. The company is advancing darovasertib to treat uveal...
🟢 IDYA makes sharp 10.2% jump
IDYA is trading at $34.41, up 10.2% versus the comparison close of $31.23 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Ideaya Biosciences Inc is trading 5.6% up today as shares rebound above the $27.00 equity offering price
Ideaya Biosciences Inc is trading 5.6% up today at $32.99, rebounding from levels seen following its recently priced equity offering. • The company announced...
🟢 Ideaya Biosciences Inc up 4.6% on Phase 1 trial momentum and new Chairman appointment
Ideaya Biosciences Inc is trading at $31.99 (4.6%) up in pre-market, extending a multi-day rebound. - The surge follows continued positive sentiment after the...
🟢 Ideaya Biosciences Inc is trading 5.8% up today after Phase 1 trial enrollment for MTAP-deleted tumors
Ideaya Biosciences Inc is trading 5.8% up at $31.98 in pre-market, extending the strong momentum seen in the previous session. • The stock continues to climb...
🟢 Ideaya Biosciences Inc. Jumps 5.4% After Initiating Phase 1 Clinical Trial for Cancer Therapy
Ideaya Biosciences Inc. is trading 5.4% up at $30.55 today following the announcement of enrolling the first patient in its Phase 1 clinical trial for IDE892...